Cargando…

Hematopoietic stem and progenitor cell harvesting: technical advances and clinical utility

Hematopoietic stem and progenitor cell (HSPC) transplantations require prior harvesting of allogeneic or autologous HSPCs. HSPCs are usually present in bone marrow (BM) during the entire life, in cord blood (CB) at birth, or in peripheral blood (PB) under particular circumstances. HSPCs were first h...

Descripción completa

Detalles Bibliográficos
Autor principal: Hequet, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340371/
https://www.ncbi.nlm.nih.gov/pubmed/25733943
http://dx.doi.org/10.2147/JBM.S52783
_version_ 1782359018497376256
author Hequet, Olivier
author_facet Hequet, Olivier
author_sort Hequet, Olivier
collection PubMed
description Hematopoietic stem and progenitor cell (HSPC) transplantations require prior harvesting of allogeneic or autologous HSPCs. HSPCs are usually present in bone marrow (BM) during the entire life, in cord blood (CB) at birth, or in peripheral blood (PB) under particular circumstances. HSPCs were first harvested in BM and later in CB and PB, as studies showed interesting features of such grafts. All harvesting methods were in use throughout the years, except BM harvesting for HSPC autologous transplantation, which was replaced by PB harvesting. BM, CB, and PB harvesting methods have been developed, and materials and devices technically improved to increase the number of HSPCs harvested. In parallel, knowing the features of the donors or patients associated with successful numbers of HSPCs allows the adaptation of appropriate harvesting methods. Moreover, it is important to ensure the safety of donors or patients while harvesting. This review describes the methods used for harvesting based on recent studies or developments around these methods, and more particularly, the means developed to increase the numbers of HSPCs harvested in each method. It also explains briefly the influence of technical improvements in HSPC harvesting on potential changes in HSPC graft composition.
format Online
Article
Text
id pubmed-4340371
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-43403712015-03-02 Hematopoietic stem and progenitor cell harvesting: technical advances and clinical utility Hequet, Olivier J Blood Med Review Hematopoietic stem and progenitor cell (HSPC) transplantations require prior harvesting of allogeneic or autologous HSPCs. HSPCs are usually present in bone marrow (BM) during the entire life, in cord blood (CB) at birth, or in peripheral blood (PB) under particular circumstances. HSPCs were first harvested in BM and later in CB and PB, as studies showed interesting features of such grafts. All harvesting methods were in use throughout the years, except BM harvesting for HSPC autologous transplantation, which was replaced by PB harvesting. BM, CB, and PB harvesting methods have been developed, and materials and devices technically improved to increase the number of HSPCs harvested. In parallel, knowing the features of the donors or patients associated with successful numbers of HSPCs allows the adaptation of appropriate harvesting methods. Moreover, it is important to ensure the safety of donors or patients while harvesting. This review describes the methods used for harvesting based on recent studies or developments around these methods, and more particularly, the means developed to increase the numbers of HSPCs harvested in each method. It also explains briefly the influence of technical improvements in HSPC harvesting on potential changes in HSPC graft composition. Dove Medical Press 2015-02-18 /pmc/articles/PMC4340371/ /pubmed/25733943 http://dx.doi.org/10.2147/JBM.S52783 Text en © 2015 Hequet. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Review
Hequet, Olivier
Hematopoietic stem and progenitor cell harvesting: technical advances and clinical utility
title Hematopoietic stem and progenitor cell harvesting: technical advances and clinical utility
title_full Hematopoietic stem and progenitor cell harvesting: technical advances and clinical utility
title_fullStr Hematopoietic stem and progenitor cell harvesting: technical advances and clinical utility
title_full_unstemmed Hematopoietic stem and progenitor cell harvesting: technical advances and clinical utility
title_short Hematopoietic stem and progenitor cell harvesting: technical advances and clinical utility
title_sort hematopoietic stem and progenitor cell harvesting: technical advances and clinical utility
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340371/
https://www.ncbi.nlm.nih.gov/pubmed/25733943
http://dx.doi.org/10.2147/JBM.S52783
work_keys_str_mv AT hequetolivier hematopoieticstemandprogenitorcellharvestingtechnicaladvancesandclinicalutility